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Abstract. High rates of morbidity and mortality in patients with chronic diseases of the kidney are for the most part 
caused by the high prevalence of cardiovascular diseases and high rates of fatal cardiovascular events. The aim of the 
study was to establish the prevalence and distribution of cardiovascular risk factors in patients with chronic kidney 
diseases, in various stages of chronic renal failure. The examinees were classified into three groups based on the level of 




; and 15-29 ml/ min/1.73m
2
. Traditional risk 
factors of age, hypertension, systolic blood pressure, glycemia, diabetes, serum level of total cholesterol and 
triglycerides, triglyceridemia, and hypertrophy  of the left ventricle showed a significantly positive rising trend of their 
mean values or prevalence, inversely dependent upon the level of declining glomerular filtration rates. Mean values of 
serum HDL cholesterol level demonstrated a significant declining trend, concomitant with decreasing glomerular 
filtration rate. The prevalence of hypercholesterolemy, smoking and obesity, as well as the mean value of body mass 
index, showed significant intergroup variations, but without any continuing trend related to glomerular filtration rate. 
Non-traditional risk factors of anemia, proteinuria, and hypoalbuminemia showed a significant rising trend of 
prevalence inversely dependent upon the degree of reduction of glomerular filtration rate. The levels of hematocrit and 
serum albumins showed a positive correlation with the reduction of glomerular filtration rate. In pre-dialysis patients 
with chronic kidney diseases, a high prevalence of the studied cardiovascular risk factors was found. Cardiovascular risk 
progressively rises with decreasing glomerular filtration rate, being significantly elevated as early as the initial stages of 
renal failure. 




Chronic kidney disease (CKD) patients are patients with 
high morbidity and mortality rates. The high mortality rate 
is for the most part caused by  high prevalence of cardio-
vascular diseases and high rates of fatal cardiovascular 
events in CKD patients. Individuals with CKDs are at a 
higher risk of dying of cardiovascular diseases thanof de-
veloping terminal kidney failure [1,2]. 
CKD patients have a three times higher incidence of 
classical, i.e. traditional cardiovascular risk factors com-
pared to the general population. Moreover, ―non-tradi-
tional‖ cardiovascular risk factors and specific changes in 
CKDs are considerably involved in the pathogenesis of 
cardiovascular diseases in chronic uremia: hypervolemia 
and renin-angiotensin-aldosteron system activation, hyper-
homocysteinemia, oxidative stress, chronic inflammation 
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and malnutrition (MIA syndrome), secondary hyperpara-
thyroidism and abnormal metabolism of calcium and 
phosphorus, disturbed acid-base balance, anemia, throm-
botic system alteration, direct effects of uremic toxins 
[3,4]. 
Aim of the Study 
The aim of the study was to establish the prevalence and 
distribution of cardiovascular risk factors in CKD pa-
tients in different stages of chronic renal failure. 
Method 
The study involved 205 CKD patients in the pre-dialysis 
stage, aged 55.14.9 years, at the Department of Neph-
rology with Dialysis Center, General Hospital Leskovac 
(Table 1). 
The examinees were divided into three groups based 
on the level of their renal function, i.e. their glomerular 
filtration rate (GFR): 
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1. slightly reduced GFR (over 60 ml/min/1.73m
2
) - 
60 examinees – group A; 
2. moderately reduced GFR (30-59 ml/min/1.73m
2
) - 
86 examinees – group B; 
3. significantly reduced GFR (15-29 ml/min/1.73m
2
) - 
59 examinees – group C. 
The prevalence of complications and comorbid condi-
tions in chronic renal failure start to grow with GFR re-
duced below 60 ml/min/1.73m
2
, so that most researchers, 
studies, and clinical guidelines tend to consider this value 
as the point of onset of hronic renal failure. The group of 
examinees with GFR of 60 ml/min/1.73m
2
 and higher was 
taken as the reference group in further analyses and com-
parisons [58]. 
Due to the fact that the MDRD equation and Cockroft-
Gault formula have got numerous limitations, especially 
when cardiovascular patients are concerned, GFR was 
determined in this study via the mean values of creatinin 
clearance in at least two samples of 24h urine creatinine 
excreation and serum creatinine. The same 24h urine was 
also used for proteinuria measurements. 
The following variables were considered the traditional 
cardiovascular risk factors: male gender, elevated blood 
pressure, obesity, diabetes, hypercholesterolemia, low 
HDL cholesterol, hypertriglyceridemia, left ventricular 
hypertrophy (LVH), smoking, as well as age, systolic and 
diastolic blood pressure values and body mass index 
(BMI). Hypertension was defined as the values of systolic 
pressure ≥140 mmHg and diastolic pressure ≥90 mmHg or 
the use of antihypertensive agents. Hypercholesterolemia 
was defined as the serum fasting cholesterol ≥6.5 mmol/l, 
≥5.0 mmol/l in the cases of an earlier myocardial infarction 
or the patient using antilipemic drugs. Left ventricular 
hypertrophy was defined, based on the echocardiographic 
test, as a thickness of the posterior left ventricle wall of 
over 11 mm, and/or interventricular septal thickness of 
over 12 mm. The criterion for diabetes was fasting serum 
glucose ≥7.0 mmol/l, serum glucose without fasting, post-
prandial,  ≥11.1 mmol/l, or the use of oral antidiabetic 
agents. Obesity was defined as the body mass index (BMI) 
>30 kg/m
2
. BMI was calculated as the ratio of body weight 
(in kg) and body surface (in m
2
) calculated from nomo-
gram tables via body height. Smoking status was defined 
as active smoker or the period of smoking of less than a 
year before the onset of the study. 
Among the non-traditional cardiovascular risk factors 
we included proteinuria, anemia, and hypoalbuminemia, as 
well as the mean values of hematocrit, leukocytes in the 
blood, serum albumin and fibrinogen. 
Cox logistic regression was used to examine the asso-
ciation of cardiovascular risk factors with glomerular fil-
tration  rates. Chi-square and Wilcoxon tests were used to 
establish the prevalence and distribution of variables. 
Results 
The values were presented as absolute in the form of mean 
values with standard deviation or in percentage form, i.e. 
the prevalence of cardiovascular risk factors. The data were 
presented for the total number of patients and by groups A, 
B, and C, based on the level of renal function. 
Table 2 presents the data for traditional cardiovascular 
risk factors. 
 The following variables showed a significant positive 
rising trend of mean values or prevalence, inversely de-
pendent upon the degree of decrease of GFR values: age, 
hypertension, systolic blood pressure, glycemia, diabetes, 
serum levels of total cholesterol and triglycerides, triglyc-
eridemia, and LVH. Serum HDL cholesterol level showed 
a significant decreasing trend of mean values in parallel 
with GFR reduction. The prevalence of hypercholesterol-
emia, smoking, and obesity, as well as the mean values of 
BMI, showed significant intergroup variations, without a 
continuing trend though related to GFR values. The prev-
Table 1  basic patient characteristics 








 205 60 / 29.3% 86 / 42.0% 59 / 28.8% 
Age (in years) 55.1  4,9 52.3  7,7 59.7  8,9 63.0 4.5 
<45 19.5% (40/205) 23.3% (14/60) 19.8% (17/86) 15.3%    (9/59) 
45-65 42.0% (86/205) 33.3% (20/60) 43.0% (37/86) 40.2%  (29/59) 
>65 38.5% (79/205) 43.3% (26/60) 37.2% (32/86) 35.6%  (21/59) 
Gender     
men 48.8% (100/205) 51.7% (31/60) 47.7% (41/86) 47.5%  (28/59) 
women 51.2% (105/205) 48.3% (29/60) 52.3% (45/86) 52.5%  (31/59) 
BMI (kg/m2) 28.0  4.5 26.8  3.8 29.4  4.2 28.6  4.4 
Kidney disease     
glomerulo(pyelo)nephritis 15.6% (32/205)  8.3%   (5/60) 19.8% (17/86) 16.9%  (10/59) 
nephro(angio)sclerosis  11.2% (23/205) 18.3% (11/60) 8.1%   (7/86) 8.5%  (5/59/) 
diabetic nephropathy 19.0% (39/205) 23.3% (14/60) 18.6% (16/86) 15.3%   (9/59) 
policystic kidney disease 6.8% (14/205) 11.7%   (7/60) 4.7%   (4/86) 5.1%   (3/59) 
endemic nephropathy 4.4%   (9/205) 8.3%   (5/60) 2.3%   (2/86) 3.4%   (2/59) 
urologic disease 12.7% (26/205) 20.0% (12/60) 12.8% (11/86) 5.1%   (3/59) 
other/unknown  30.2% (62/205) 16.7% (10/60) 33.7% (29/86) 39.0% (23/59) 
BMI – body mass index  
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alences of male gender, low HDL, as well as the mean 
values of diastolic pressure, did not show any significant 
intergroup variations. 
Anemia, proteinuria, and hypoalbuminemia showed a 
significant rising prevalence trends, inversely dependent 
upon the degree of reduction of glomerular filtration, i.e. 
the prevalence of the above variables increased in parallel 
with the decline of renal function. The levels of hematocrit 
and serum albumins showed a positive correlation with 
decreasing GFR, i.e. a significant decrease dependent upon 
the decreasing renal function. The number of leukocytes in 
the peripheral blood smear and level of serum fibrinogen 
did not demonstrate any significant intergroup variations. 
Discussion 
Risk factor burden, for both traditional and non-traditional 
factors, is significantly higher among the patients with 
chronic kidney disease compared to the general population. 
However, this burden varies significantly with patient 
characteristics, including the degree of renal dysfunction 
and cause of renal disease. Even after correction for the 
factors of gender, age, race, elevated blood pressure, 
cardiovascular disease, diabetes, and other demographic 
characteristics, a relatively strong association was still 
present between the total burden with cardiovascular risk 
factors and GFR lower than 60 ml/min/1.73m
2
 [4,5,9,10]. 
Within the Modification of Diet in Renal Disease 
(MDRD) study, Sarnak et al. [11] found out that traditional 
risk factors were highly prevalent in hronic kidney disease 
and that their prevalence varied based on the level of renal 
Table 2  Cardiovascular risk factors  




30 – 59  
ml/min 
15 – 29    
ml /min 
 205 60  86  59  
Traditional risk factors     
Age *+ 55.1    4.9 52.3  7.7 59.7  8.9 63.0 4.5 
gender (male) *o 48.8% (100/205) 51.7% (31/60) 47.7% (41/86) 47.5% (28/59) 
hypertension % *+ 65.4% (134/205) 46.7% (28/60) 67.4% (58/86) 81.4% (48/59) 
systolic blood pressure mmHg *+ 139  12.6 135  11.9 143  15.3 149  13.8 
diastolic blood pressure mmHg *o 85    4.4 84  3.9 86  9.1 87  7.1 
obesity % *± 27.3%  (56/205) 20.0% (12/60) 31.4% (27/86) 28.8% (17/59) 
BMI (kg/m2) *± 28.0    2.5 26.8  1.8 29.4  2.2 27.9  3.4 
glycemia mmol/l *+ 6.33  0.74 6.08  0.52 6.54  1.13 7.11  0.96 
diabetes % *+ 18.5%  (38/205) 15.0%  (9/60) 17.4% (15/86) 23.7% (14/59) 
total cholesterol mmol/l *+ 5.82  0.81 5.53  1.20 5.71  0.77 6.26  1.35 
hypercholesterolemia % *± 24.9%  (51/205) 18.3% (11/60) 29.1% (25/86) 25.4% (15/59) 
HDL mmol/l *- 1.25   0.56 1.32  0.47 1.15  0.30 1.00  0.34 
low HDL % *o 6.3%  (13/205) 6.7%  (4/60) 5.8%  (5/86) 6.7%  (4/59) 
triglycerides mmol/l *+ 2.18  1.13 1.19  0.60 1.90  0.72 2.94  0.88 
hypertriglyceridemia % *+ 24.4%  (50/205) 18.3% (11/60) 24.4% (21/86) 30.5% (18/59) 
hypertrophy LV % *+ 22.9%  (47/205) 18.3% (11/60) 22.1% (19/86) 28.8% (17/59) 
smoking % *± 24.9%  (51/205) 31.7% (19/60) 20.9% (18/86) 23.7% (14/59) 
Legend: *+  -   positive trend          
 *-   -   negative trend                                 
 *±  -   inter-group variations without a continuous trend                                  
 *o  -   without trend and without intergroup variations 
Table 3  Cardiovascular risk factors  II 




30 – 59  
ml/min 
15 – 29 
ml/min 
 205 60 86 59 
Non-tradicional risk factors     
proteinuria %  *+ 20.0% (41/205) 11.3%   (8/60) 17.4% (15/86) 30.5% (18/59) 
microalbuminuria % *± 28.3% (58/205) 21.7% (13/60) 32.6% (28/86) 28.8% (17/59) 
anaemia % *+ 25.4% (52/205) 10.0%  (6/60) 25.6% (22/86) 40.7% (24/59) 
hematocrit % *- 38    3.7 42    5.6 39    4.3 33    2.5 
leukocytes 109/l *o 6.20  0.89 6.17  0.93 5.98  1.05 6.24  1.44 
S - albumin g/l *- 39.0  7.7 40.9    5.8 38.7    6.6 37.2    4.4 
S - albumin  3.5 g/l % *+ 7.8% (16/205) 5.0%  (3/60) 5.8%  (5/86) 13.5%  (8/59) 
S - fibrinogen g/l *o 3.15  0.54 3.16  0.27 3.03  0.63 3.22  0.48 
Legend: *+  -   positive trend                               
 *-   -   negative trend                                   
 *±  -   inter-group variations without a continuous trend                                   
 *o  -   without trend and without inter-group variations 
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function, that GFR was inversely correlated with blood 
pressure level and positively correlated with serum HDL 
cholesterol level, while there were no associations with 
LDL cholesterol. In our examinees, systolic blood pressure 
and serum total cholesterol and triglyceride levels rose in 
parallel with declining GFR. Diastolic blood pressure was 
without any significant variations related to GFR altera-
tions. There were 65.4% hypertensive individuals among 
the examinees, with an observed growing trend with de-
creasing GFR. 
Jingers et al. [12] in their prospective study that lasted 
over 10 years observed an abnormally high incidence of 
atherosclerotic cardiovascular complications in pre-dialysis 
patients with CKD in all age groups and in both genders; 
their total incidence was almost three times higher than that 
in the general population. Smoking, poor blood pressure 
control, dyslipidemia with low serum HDL cholesterol, as 
well as higher degrees of hyperfibrinogenemia and hyper-
homocysteinemia were present in CKD patients in whom 
atherosclerotic cardiovascular complications developed. 
The same factors favoring atherogenesis in the general 
population, such as hypertension, smoking or dyslipidemia, 
were present in CKD patients, but with potentiated effects, 
so that the incidence and severity of these disorders were 
higher in uremic patients. Among our examinees, there 
were 24.9% (51/205) smokers. Smoking is a very im-
portant, independent risk factor. Atherogenic effects of 
smoking in uremic patients are particularly striking due to 
increased free radical production and consequential lipid 
peroxidation, nevertheless increased in uremic pa-
tients [13]. 
In the reports by Foley et al. [1,5], individuals with re-
nal failure were older, male, diabetic, with elevated blood 
pressure, smokers, and physically inactive. Hypertension is 
in CKD the principal risk factor for cardiovascular athero-
sclerotic events (especially a high systolic blood pressure). 
Our examinees were 55.14.9 years old on average, being 
older with declining GFR values. Male gender was more 
prevalent, with 48.8% (100/205), and the ratio did not 
change with the progression of chronic renal failure. The 
average prevalence of diabetes was 18.5% (38/205), with 
average serum glucose 6.33±0.74 mmol/l. The prevalence 
of diabetes in group C, with lowest GFR values, was 
23.7% (14/59). LVH was present in 22.9% (47/205), ac-
cording to the echocardiographic parameters, with an in-
cresing prevalence in CKD patients with progressively 
lower GFR values. 
It is well known that lipid parameters are markedly al-
tered in CKD patients compared to the general population, 
but the changes are more intense in patients with cardio-
vascular events [3,10,12]. Uremic dyslipidemia, i.e. low 
HDL cholesterol values, is the major and independent car-
diovascular risk factor that occurs early during the course 
of chronic renal failure. Jungers et al. [12] showed that 
total and LDL serum cholesterol, apoB and triglyceride 
levels were significantly higher, while HDL cholesterol 
was lower, in the group of kidney patients with cardiovas-
cular accidents compared to those without accidents. HDL 
cholesterol alterations in our examinees were very inter-
esting. Expressed in absolute values, low HDL cholesterol 
was seen in 6.3% (13/205) of the examinees, and the aver-
age serum value of HDL cholesterol was 1.25±0.56 
mmol/l, as described in several other studies as well 
[11,14]. The mean values of serum HDL cholesterol 
demonstrated a significant declining trend in parallel with 
declining GFRs, but viewed through the prevalence of 
patients with low HDL cholesterol values, this risk factor 
did not demonstrate any significant intergroup differences. 
The total prevalence of hypercholesterolemia was 24.9% 
(51/205), being significantly higher in groups B and C 
compared to group A, with the average serum cholesterol 
value of 5.82±0.81 mmol/l. Increased triglyceride levels 
were encountered in 24.4% (50/205), with an average se-
rum triglyceride value of 2.18±1.13 mmol/l. Hypertriglyc-
eridemia was most prevalent in group C, with 30.5% 
(18/59). 
McDonald et al. [15,16] reported a very high rate of 
pathological albuminuria among the members of a small 
community of Aboriginal people, the ethnic group with a 
high incidence of terminal renal failure. Their high levels 
of albuminuria were associated with low levels of esti-
mated glomerular filtration rate. Albuminuria was also 
accompanied by increased BMI, elevated blood pressure, 
elevated HbA1 levels and diabetes. The total proportion of 
our patients with proteinuria was 20.0% (41/205), with the 
prevalences of proteinuria and serum hypoalbuminemia on 
the rise with the progression of chronic renal failure, and 
inversely dependent upon declining GFR values. 
The issues of obesity and chronic renal failure have 
been investigated in numerous studies, attempting to 
prove the cause and effect relationship between a rising 
BMI and declining GFR [17]. In this study, there were 
27.3% (56/205) obese examinees, with the average BMI 
of 28.0±2.5 kg/m
2
. Obesity and mean BMI values 
showed significant intergroup variations and were with-
out any continuing trend related to declining GFR. 
The levels of hematocrit and prevalence of anemia in 
our examinees showed a positive correlation with declining 
GFR, i.e. a significant declining trend depending upon the 
declining renal function. The serum level of fibrinogen did 
now show any significant intergroup variations. In contrast, 
in the studies by Jungers et al. [12] and Muntner et al. [9]   
the serum level of fibrinogen was conspicuously higher in 
CKD patients compared to the healthy individuals, and 
significantly higher in CKD patients with cardiovascular 
events compared to the healthy individuals. 
The number of leukocytes in the peripheral blood 
smear did not show any significant intergroup variations. 
Some studies have reported that leukocytes behave like 
non-traditional risk factors and as such, they are elevated 
in CKD [9, 18]. 
Conclusion 
In pre-dialysis CKD patients, a high prevalence of the 
examined traditional and non-traditional cardiovascular 
risk factors was established. The cardiovascular risk 
progressively rises with declining GFR values, and the 
risk is significantly elavated already in the initial stages 
of chronic renal failure. 
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